Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients
- PMID: 30151604
- DOI: 10.1007/s11916-018-0729-x
Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients
Abstract
Purpose of review: The aim is twofold. First, to give an insight on the role exerted by different classes of drugs in favouring migraine chronification. Second, to explore the relationship between type and amount of overused medications and history of previous withdrawal treatment and of frequent relapses.
Recent findings: All drug classes were found to favour migraine chronification. No data are available for the association with relapses into CM-MOH. Our clinical study shows that patients who underwent previous withdrawal treatments were more likely to be overusers of multiple drug classes and overuse higher amounts of symptomatic medications, particularly, indomethacin, eletriptan and tramadol. Frequent relapsers were more likely to be overusers of opioids or ergotamine and caffeine derivates or of multiple classes, particularly acetylsalicylic acid and ergotamine/caffeine derivates. The joint results our review and clinical study do not seem to support the idea that MOH is drug-specific: rather, it points out that all drug classes may induce migraine chronification. Those drugs which are at higher risk of overuse are among those preferred by the "worst" patients, i.e. those who needed one or more withdrawal treatments for MOH. Our results reinforce the clinical impression that patients with CM and MOH, and particularly the most difficult to treat for their poor response to withdrawal treatments, are characterised by a particular drive towards the consumption of "whatever is likely to be perceived to provide some relief", despite these drugs that are perceived as "more powerful", are often indicated as second- or third-line medications.
Keywords: Anti-inflammatory drugs; Chronic migraine; Medication-overuse headache; Opioids; Triptans; Withdrawal.
Similar articles
-
Risk of medication overuse headache across classes of treatments for acute migraine.J Headache Pain. 2016 Dec;17(1):107. doi: 10.1186/s10194-016-0696-8. Epub 2016 Nov 24. J Headache Pain. 2016. PMID: 27882516 Free PMC article. Review.
-
Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project.J Headache Pain. 2015;16:83. doi: 10.1186/s10194-015-0561-1. Epub 2015 Sep 18. J Headache Pain. 2015. PMID: 26382855 Free PMC article.
-
Clinical characteristics of medication-overuse headache according to the class of acute medication: A cross-sectional multicenter study.Headache. 2022 Jul;62(7):890-902. doi: 10.1111/head.14363. Epub 2022 Jul 14. Headache. 2022. PMID: 35833500
-
The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.BMC Neurol. 2021 Nov 2;21(1):425. doi: 10.1186/s12883-021-02451-x. BMC Neurol. 2021. PMID: 34727873 Free PMC article.
-
Medication-overuse headache.Continuum (Minneap Minn). 2012 Aug;18(4):807-22. doi: 10.1212/01.CON.0000418644.32032.7b. Continuum (Minneap Minn). 2012. PMID: 22868543 Review.
Cited by
-
Is there a sex difference in adult salivary clearance of caffeine (1,3,7-trimethylpurine-2,6-dione)?J Oral Biol Craniofac Res. 2020 Apr-Jun;10(2):20-22. doi: 10.1016/j.jobcr.2020.01.010. Epub 2020 Feb 6. J Oral Biol Craniofac Res. 2020. PMID: 32071850 Free PMC article.
-
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.Cephalalgia. 2020 Aug;40(9):903-912. doi: 10.1177/0333102420920006. Epub 2020 Jun 24. Cephalalgia. 2020. PMID: 32580575 Free PMC article.
-
The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.J Headache Pain. 2019 May 16;20(1):54. doi: 10.1186/s10194-019-1007-y. J Headache Pain. 2019. PMID: 31096904 Free PMC article. Review.
-
Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study).J Headache Pain. 2023 Jul 14;24(1):86. doi: 10.1186/s10194-023-01630-0. J Headache Pain. 2023. PMID: 37452281 Free PMC article. Clinical Trial.
-
Medication-overuse headache: clinical profile and management strategies.Neurosciences (Riyadh). 2023 Jan;28(1):13-18. doi: 10.17712/nsj.2023.1.20220115. Neurosciences (Riyadh). 2023. PMID: 36617449 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials